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Abstract 
Rs-AFP2 is a 51 amino acid cysteine-rich peptide isolated from radish (Raphanus sativus) seeds that exhibits potent inhibitory activity against 
filamentous fungi. A cDNA clone encoding the Rs-AFP2 preprotein was modified by recombinant DNA methods to allow expression in the yeast 
Saccharomyces cerevisiae. This peptide was expressed in yeast as a fusion protein carrying at its N-terminus the prepro-sequences derived from the 
precursor of the yeast pheromone mating factor al. These sequences allow secretion of the biologically active peptide in a correctly processed form. 
Deletion of the mating factor al pro-peptide drastically reduced the expression level of the peptide. 
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1. Introduction 
Recently, we have described a new class of antifungal 
proteins occurring in seeds of radish [l] and at least four 
other Brassicaceae species [2]. These proteins specifically 
inhibit a range of filamentous fungi and have no adverse 
effects on yeast (Succharomyces cerevisiae), bacteria or 
cultured human cells [l]. They consist of small 5 kDa 
polypeptides that are highly basic and rich in cysteine. 
The primary structures of the two isoforms from radish 
seeds, Rs-AFPl and Rs-AFP2, only differ at two posi- 
tions: the Glu at position 5 in Rs-AFPl is a Gln in 
Rs-AFP2, and the Asn at position 27 in Rs-AFPl is 
substituted by an Arg in Rs-AFP2. Although both Rs- 
AFPs are 94% identical at the amino acid sequence level, 
Rs-AFP2 is two- to thirty-fold more active than Rs- 
AFPl on various fungi [l]. This observation suggests 
that small alterations in the primary structure of these 
proteins may entail significant changes in their capacity 
to inhibit growth of filamentous fungi. It would therefore 
be worthwhile to investigate structure-activity relation- 
ships of the Rs-AFPs using site-directed mutagenesis. A
prerequisite for such studies, however, is the availability 
of an efficient expression system allowing production of 
the proteins in a biologically active form. 
The cDNA encoding Rs-AFPl has recently been 
cloned [3] and shown to encode a preprotein with a signal 
peptide followed by the mature protein. Using recombi- 
nant DNA methods the cDNA encoding the Rs-AFP2 
preprotein was modified to allow expression in S. cere- 
visiae. In this study we show that S. cerevisiae can be 
*Corresponding author. Fax: (32) (16) 200 720. 
Abbreviations: Rs-AFP, Raphanus sativus antifungal protein; I& pro- 
tein concentration required for 50% inhibition of fungal growth. 
used as a vector for the production and secretion of 
Rs-AFP2. 
2. Materials and methods 
2.1. Strains 
Plasmid cloning was done in Escherichia coli strain DH5cc. The yeast 
(S. cerevisiae) strain c13-ABYS86 (genotype: apral-1, prbl-1, cpsl-3, 
ura3d5, leu2-3, 112, his-), was used for protein expression. The fungal 
strains used to test antifungal activity were Fusarium culmorum (IMI 
180420) and Ascochyta pisi (MUCL 20164). 
2.2. Plasmid construction 
Plasmid pFRG1 is a pBluescript IISK derivative containing a full- 
length cDNA clone encoding Rs-AFPl [3]. By PCR-mediated site- 
directed mutagenesis [4], two mutations were introduced such that the 
encoded protein is the more active isoform Rs-AFP2) [3]. In this study, 
a third mutation (CGA to CGT for Arg” of mature Rs-AFP2) was 
introduced to comply with the codon usage preference in S. cerevisiae 
[5]. The resulting plasmid was called pBluescript/RsAFP*. 
The vectors pMFprelRsAFP2 and pMFpreprolRsAFP2 are based 
on the yeast/E. coli shuttle vector pTG3828 [6]. pTG3828 contains a 
URA3-d selection marker, the origin of replication from the yeast 2 p 
plasmid, the prokaryotic ColEl origin of replication and the ampicillin 
resistance marker from pBR322. pTG3828 also contains the yeast 
phosphoglycerate kinase (PGK) terminator preceded by a polylinker 
with multiple unique restriction sites which facilitate insertion of an 
expression block. 
The expression blocks in pMFpreiRsAFP2 and pMF prepro/ 
RsAFP2 were derived from the Ml 3 phage derivative M 13TG5879 [7] 
which contains the promoter of the yeast mating factor al (M&Z) 
gene, the coding region of the MFaI pre-sequence with an engineered 
NheI site, and the coding region of the MFuI pro-sequence with an 
engineered Hind111 site. The expression cassette of M13TG5879 
was amplified by PCR using a sense primer (S’TATCA- 
GTCGACGCATGCTATTGATAAGATTTAAAGG, SalI site un- 
derlined, SphI site double underlined), which introduces a novel SalI 
site immediately adjacent o the SphI site at the 5’ end of the MFal 
promoter, and the Ml3 reverse primer as an antisense primer. The 
resulting PCR product was digested with San-BamHI and subcloned 
into pBluescriptI1 SK to yield pVD4. 
Plasmid pBluescript/RsAFP2* (see above) was used as a template for 
the amplification of the coding sequence of mature Rs-AFP2 in two 
separate PCR reactions. In the first PCR reaction the sense primer 
(S’AATAAGCTTGGACAAGAGACAGAAGTTGTGCCAAAGG, 
Hind111 site underlined) was designed such that sixteen extra nucleo- 
tides (coding for the last five amino acids of the MFaZ pro-sequence) 
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were added upstream of the coding region of mature Rs-AFP2. The 
Hind111 site allowed in frame cloning into the Hind111 site in the 
MFal prosequence region of pVD4 [7]. The antisense primer (5’AA- 
GGATCCCTAITAACAAGGAAAGTAGC, BamHI site underlined) 
introduced a second stop codon and a BumHI site immediately down- 
stream of the stop codon of the coding region of Rs-AFP2. In the 
second PCR reaction, the same antisense primer was combined with a 
different sense primer (5’AATGCTAGCTCAGAAGTTGTGCCA- 
AAGG, NheI site underlined) whiched seven extra nucleotides 
(coding for the last two amino acids of the MFal presequence), includ- 
ing a NheI site (for in frame cloning into the NheI site in the MFal 
presequence region of pVD4) upstream of the coding region of mature 
Rs-AFP2. The fragments corresponding to the mature domain of Rs- 
AFP2 obtained by PCR amplification in the first and in the second 
reaction were digested with HindIII-BamHI and NheI-BamHI, respec- 
tively, and introduced in the corresponding sites of pVD4 to yield 
vectors pVD5 and pVD6, respectively. The resulting vectors were di- 
gested with SaiI-BamHI to isolate the expression blocks, which were 
then subcloned into Salr-BgBI digested pTG3828 to yield the vectors 
pMFpre/RsAFP2 and pMFprepro/RsAFP2, respectively (Fig. 1.). 
These plasmids and plasmid pTG3828 were transformed in yeast by the 
lithium acetate method as described by Elble [8]. Selection of transfor- 
mants was done on minimal selective SD medium lacking uracil [9]. 
Presence of the plasmids in the yeast colonies was verified by PCR as 
described by Ward [lo]. 
All constructs modified by PCR-based mutagenesis were checked by 
DNA sequencing using the AutoRead Sequencing Kit (Pharmacia, 
according to the manufacturer), and a Pharmacia A.L.F. DNA Se- 
quencer. 
2.3. Antifungal activity assay 
2.3.1. Plate growth inhibition assay. Minimal selective SD medium 
containing 0.6 g/l of agar was autoclaved, cooled to 40°C and supple- 
mented with spores of A. pisi (lo4 spores/ml hnal spore density) before 
pouring into petri dishes. A suspension of transformed yeast cells (10’ 
cells/ml) was dispersed as 2 ~1 drops on top of the spore containing agar 
medium. The plates were incubated for 24 h at 30°C followed by 2-5 
days incubation at room temperature. Inhibition halos indicating zones 
of suppressed growth of A. pisi were viewed macroscopically. 
2.3.2. Liquid growth inhibition assay. The supematant of saturated 
yeast cultures or different fractions from chromatographic purification 
steps were filtered (sterile 0.22 pm filter) and serially diluted in sterile 
water. Diluted samples (20 ~1) were incubated in microtiter plate wells 
with 80 ~1 of half strength potato dextrose broth (Difco) containing 
spores (IO4 spores/ml) of E culmorum. Growth of the fungi was moni- 
tored by microspectrophotometry asdescribed by Broekaert et al. [l 11. 
Homogenates of yeast cells were prepared by spinning down 1 ml of 
a saturated yeast culture, suspending the cells in 200@ of water, vortex- 
ing the cells in the presence of 0.2 g of glass beads (425-600 pm), and 
clearing the homogenate by centrifugation (1 min, 10,000 x g). 
2.4. P@ication of Rs-AFP2 from yeast culture 
The supematant of 100 ml of a saturated culture of transformed yeast 
(grown on minimal selective SD medium supplemented with 0.5% (w/v) 
of casamino acids) was centrifuged (4000 rpm, 10 min), and filtered 
(0.45 pm) to remove yeast cells and debris. Tris-HCI (pH 9) was added 
to the supematant to a final concentration of 50 mM. The sample was 
loaded at a flow rate of 2 ml/min on an anion exchange chromatogra- 
phy column (Q-Sepharose Fast Flow, 20 ml bed volume, Pharmacia), 
on-line connected with a disposable reversed-phase C8 silica column 
(Bond Elut, 500 mg solid phase, Varian, Harbor City, USA). The 
antifungal activity was not retained on the Q-Sepharose matrix but 
bound to the C8 silica matrix. The C8 silica column was rinsed with 
6 ml of 10% (v/v) acetonitrile n 0.1% (v/v) trifluroacetic a id (TFA) and 
subsequently eluted with 4 ml of 30% (v/v) acetonitrile in 0.1% (v/v) 
TFA. The latter eluate was dried in a rotating vacuum concentrator, 
redissolved in 0.5 ml 15% (v/v) acetonitrile containing 0.1% (v/v) TFA, 
and was loaded on a reversed-phase C2/Cl8 silica column (Pep-S, 5 pm 
beads, 0.4 x25 cm, Pharmacia) connected to a Waters 600 HPLC sta- 
tion. Chromatography parameters are given in the legend to Fig. 2. 
2.5. Protein analytical methods 
The bicinchoninic acid method 1121 adapted to a microplate format was 
used for protein concentration determination. Bovine serum albumin 
served as a reference protein. N-terminal amino acid sequence was done 
by automated Edman degradation in a 477A Protein Sequenator (Ap- 
plied Biosystems Inc., Foster City, CA) with on-line detection of phen- 
ylthiohydanthoin derivatives in a 120-A PTH Analyzer (Applied Bio- 
systems). Prior to amino acid sequence analysis, cysteine residues were 
modified by S-carboxyamido-methylation as described previously [l]. 
Digestion of proteins with pyroglutamate aminopeptidase (sequencing 
grade, Boehringer Mannheim) was done according to the supplier’s 
instructions. 
3. Results 
3.1. Construction of vectors 
Two different plasmids were constructed for testing 
the ability to express active Rs-AFP2 in the yeast 
S. cerevisiue. These plasmids, pMFpre/RsAFP:! and 
pMFprepro/RsAFP2, contain the coding region of the 
mature Rs-AFP2 fused in frame with the predomain or 
preprodomain, respectively, of the yeast mating factor 
MEal gene. In these constructs the promoter is the 
M&l promoter and the plasmid backbone is that of the 
yeast/E. coli shuttle vector pTG3828 [6]. Both pMFpre/ 
RsAFP2 and pMFprepro/RsAFP2 carry the preferred 
yeast codon (CGA) at arginine 32 of mature Rs-AFP2 
instead of the natural codon (CGT) present in the 
cDNA. All the other codons of the Rs-AFP2 coding 
region are frequently used by S. cerevisiae [5]. 
pMFprepro/RsAFFQ pMFprdRsA”‘2 
/J 
Fig. 1. Schematic representation of the construction of the expression 
vectors pMFpreprolRsAFP2 and pMFpre/RsAFPZ. The different 
steps in the procedure are: (1) PCR amplification of the coding region 
of mature RsAFP2 using primers to add a Hind111 site and part of the 
MFal pro region (5’ site) and a BamHI site (3’ site); (2) PCR amplifi- 
cation of the coding region of mature RsAFP2 using primers to intro- 
duce a NheI and part of the MFal pre region (5’site) and a BamHI site 
(3’ site); (3) subcloning of the PCR product into HindIII-BamHI di- 
gested pVD4; (4) subcloning of the PCR product into NheI-BamHI 
digested pvD4; (5) digestion of the resulting plasmids with SalI-BamHI 
and subcloning of the insert in .Sa[I-BgBI digested pTG3828. Abbrevi- 
ations: pre, signal sequence domain of RsAFPl cDNA; prea, signal 
sequence domain of the MFal gene; proa, propeptide domain of the 
MFaZ gene; pMFa 1, promoter domain of the MFaI gene; tPGK, 
terminator domain of the yeast phosphoglycerate kinase gene. 
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Fig. 2. Reversed-phase chromatography purification of yeast-expressed 
Rs-AFP2. The sample loaded on the column was derived from 100 ml 
of culture medium of yeast transformed with pMFpreprolRsAFP2 as 
described in materials and methods. The column (C2K18 silica, 5 pm 
beads, 0.4 x 25 cm, Pharmacia) was equilibrated with 15% acetonitrile 
containing 0.1% TFA and was rinsed after loading with the same buffer 
until the absorbance reached background level. The column was subse- 
quently eluted with a 15 min linear gradient from 15% to 50% acetoni- 
trile containing 0.1% TFA at a flow rate of 1 ml/mm. The eluate was 
monitored for proteins by one-line measurement of the absorbance at 
280 nm. Peak fractions were collected manually, dried in a rotating 
vacuum concentrator to remove the solvents, and redissolved in 200 ~1 
of distilled water. Twenty ,~l fractions were tested in the liquid growth 
inhibition assay. Only the peak fractions indicated by A and B exhibited 
antifungal activity. The elution time indicated in the abscissa is relative 
to the start of the elution gradient. 
3.2. Secretion of the active Rs-AFP2 by yeast 
Plasmids pTG3828, pMFprepro/RsAFP2, pMFpre/ 
RsAFP2 were transferred to yeast. Transformants were 
selected and tested for their capacity to secrete active 
Rs-AFP2. A plate assay was developed in which yeast 
colonies were spotted on a selective medium containing 
fungal spores. A faint inhibition zone was visible only 
underneath the yeast colonies transformed with the 
pMFprepro/RsAFP2 vector (results not shown). 
The active material secreted into the culture medium 
by yeast transformants was subsequently evaluated by a 
liquid growth inhibition assay using L culmorum as a test 
fungus. To assess for possible intracellular accumulation 
of Rs-AFP2, yeast cells were homogenized and the re- 
sulting homogenates also assayed using liquid growth 
inhibition tests. Antifungal activity could only be de- 
tected in the culture medium of yeast cells transformed 
with pMFprepro/RsAFP2, which contained about 2 flgi 
ml of Rs-AFP2 equivalents. The activity of the homoge- 
nate of these cells, as well as that of culture media and 
cell homogenates of yeast cells transformed with 
pMFprelRsAFP2 or pTG3828 transformed yeasts was 
below the detection limit (about 0.2 ,~&ml of Rs-AFP2 
equivalents). Hence, only pMFprepro/RsAFP2 seems to 
convey significant expression of Rs-AFP2 in yeast. We 
have consequently retained this vector in subsequent ex- 
periments. 
3.3. PuriJication of yeast-expressed Rs-AFP2 
After two initial purification steps consisting of anion- 
exchange chromatography on Q-Sepharose Fast Flow 
and passage over a disposable C8 silica column, the par- 
tially purified culture medium of pMFprepro/RsAFP2- 
transformed yeast cells was applied on a reversed-phase 
chromatography (RPC) column consisting of CUCl8 sil- 
ica. Fig. 2 shows the RPC profile in which both the main 
peak (peak A, elution time 14.7 min) and a smaller peak 
(peak B, elution time 15.2 min) coeluted with antifungal 
activity. The retention time of peak B was identical to 
that of authentic Rs-AFP2 (15.2 mm). 
3.4. Analysis of yeast-expressed Rs-AFP2 
The amino-terminal amino acid sequence obtained by 
automated Edman degradation for RPC-purified peak A 
revealed a sequence of 5 1 amino acids, all of which being 
identical to the sequence of Rs-AFP2 (Fig. 3). This se- 
quence includes an N-terminal glutamine which is 
known to be blocked by cyclisation in authentic Rs- 
AFP2 [l]. Absence of any contaminating signals in the 
amino acid sequence analysis indicated that the peak A 
fraction was essentially homogeneous. No sequence sig- 
nals could be recorded for RPC-purified peak B mate- 
rial, probably due to blocking of its N-terminus. This 
protein fraction was treated with pyroglutamate amin- 
opeptidase in order to cleave off the presumed blocked 
glutamine residue, but also in this case no amino acid 
sequence could be determined, whereas the same treat- 
ment successfully deblocked authenthic RAFP2 [l]. Be- 
cause of the uncertain identification of the peak B mate- 
rial and because of its lower abundancy relative to peak 
A material, the peak B material was not further analysed. 
The specific antifungal activity of RPC-purified peak 
A material, as well as that of authentic Rs-AFP2, was 
determined by measuring the percentage growth inhibi- 
tion of K culmorum caused by serial dilutions of the 
protein samples. The IC,, values (concentration required 
for 50% growth inhibition) derived from dose-response 
curves, was about 3 &ml for both protein preparations 
(Fig. 4A). 
Moreover, the type of inhibition caused by RPC-puri- 
fied peak A material was identical to that caused by 
peakA QKLCQRPSGTWSGVCGNNNACKNQCINLEKAFMGSCNYVFPAHKCICYFPC 
Rs-AFP2 KLCQRPSGTWSGVCGNNNACKNQCINLEKARHGSCNYVE'PAHKCICYFPC 
Fig. 3. Amino acid sequences of peak A fraction (untreated), and 
authentic Rs-AFP2 (obtained after digestion with pyroglutamate amin- 
opeptidase [l]). The underlined amino acid sequence is derived from a 
cDNA clone encoding Rs-AFP2 [3]. 
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Fig. 4. (A) Dose-response curves for growth inhibition of Fusarium 
culmorum by peak A material (D), and authentic Rs-AFP2 (ll). Growth 
inhibition was measured bymicrospectrophotometry after 24 h of incu- 
bation (B). Microscopic view of F. culmorum grown for 24 h in the 
absence (a) or presence of10/zg/ml peak A material (b), or10/zg/ml 
Rs-AFP2 (c). 
authentic Rs-AFP2, showing a characteristic morpho- 
logical distortion of the fungal hyphae typified by the 
induction of multiple branches near the tips (Fig. 4B). 
4. Discussion 
The aim of the present study was to develop an expres- 
sion system allowing facile production of the antifungal 
protein Rs-AFP2 for detailed analysis of its active site by 
mutational analysis. The occurrence of multiple disulfide 
bridges in authentic Rs-AFP2 [1] prompted us to use an 
eukaryotic expression system, since it is known that di- 
sulfide bridge formation of eukaryotic proteins 
expressed in prokaryots is often erratic, leading to un- 
proper folding. Yeast was chosen for expression of Rs- 
AFP2 since, notwithstanding its potent inhibitory effect 
on filamentous fungi, this protein does not have adverse 
effects on yeast even at concentrations a  high as 500 
/ag/ml [11. 
Two different chimeric onstructs were made based on 
the MFotl expression system. In one construct, the Rs- 
AFP2 coding region was fused immediately behind the 
pre-sequence of the MFotl gene, while in the other con- 
struct it was placed behind the prepro-sequence of the 
MFo~I gene. In both cases transcription was regulated by 
the MF~I  promoter. As shown by the liquid growth 
inhibition assay, only the prepro-fusion led to secretion 
of active Rs-AFP2. Deletion of the pro-region resulted 
in reduction of Rs-AFP2 secretion by at least 10-fold. 
Furthermore, arlier attempts to use the authentic signal 
sequence of Rs-AFP2 did not allow efficient secretion of 
Rs-AFP2 in yeast (Vilas Alves, unpublished results). 
Reichhart et al. [7] have also observed that production 
of recombinant insect defensin A in yeast was about 
40-fold higher using a MF~I  prepro-fusion than with a 
MF~I  pre-fusion. On the other hand, Achstetter et al. [6] 
found that expression of leech hirudin in yeast as a MFo~I 
prepro-fusion protein was about four times lower than 
a comparable MF~I  pre-hirudin fusion, whereas expres- 
sion of MF~I  prepro-and pre-human cathepsin S was 
equally efficient in yeast [13]. Apparently, the effect of 
the MF~I  pro-sequence on the secretion of a heterolo- 
gous protein is dependent on the structure of that pro- 
tein. It is noteworthy that Rs-AFP2 belongs to a family 
of plant proteins that comprises the y-thionins from cere- 
als [1]. y-Thionins have recently been shown to have a 
three-dimensional structure similar to that of insect de- 
fensins [14]. The striking requirements of the MF~I  pro- 
domain for expression of both types of structurally re- 
lated proteins may be explained by assuming that the 
pro-domain facilitates correct folding of the mature do- 
main. Alternatively, the absence of the pro-domain may 
somehow hamper proper co-translational processing in 
the endoplasmic reticulum of yeast. 
During the purification of yeast-expresed Rs-AFP2 by 
reversed-phase chromatography, two protein fractions 
exhibiting antifungal activity, called peak A and peak B 
material, were recovered. Peak A material has exactly the 
same amino acid sequence as authentic Rs-AFP2 except 
that its N-terminal glutamine is not cyclisized. This 
difference is deduced from the observation that amino- 
terminal sequencing of authentic Rs-AFP2 requires pre- 
treatment with the enzyme pyroglutamate aminopepti- 
dase, whereas that of peak A material does not. Despite 
of this minor difference between the yeast-expressed Rs- 
AFP2 and plant-derived Rs-AFP2, both proteins have 
exactly the same antifungal activity, indicating that N- 
terminal cyclisation has no effect on the biological prop- 
erties of the protein. Peak B material could not be further 
identified since no amino acid sequence signals could be 
obtained even after pyroglutamate aminopeptidase di- 
gestion. This protein is likely to be a processing or 
amino-terminal derivatisation analog of Rs-AFP2. 
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